Menu

Genetic Clues in the Newtown Massacre

Investigators are calling on scientists to comb Adam Lanza’s DNA for potential drivers of his violent behavior last week in Connecticut.

Dec 20, 2012
Bob Grant

Police at Sand Hook Elementry, after the shooting on December 14, 2012.WIKIMEDIA< VOAOfficials in Connecticut are searching for any clues that may help them piece together the motivations of Adam Lanza, the 20-year-old man who killed his mother before going on a deadly shooting spree in an elementary school last Friday (December 14), gunning down 20 young children, and 6 other adults in the idyllic New England town of Newtown. According to The Hartford Courant, H. Wayne Carver, Connecticut’s chief medical examiner, has invited a University of Connecticut geneticist to join him in the investigation of the killings. “I’m exploring with the department of genetics what might be possible, if anything is possible,” Carver told the Courant on Tuesday. “Is there any identifiable disease associated with this behavior?”

Some sources have averred that Lanza had Asperger’s syndrome, an autism spectrum disorder, but that has yet to be definitively determined. Carver told the Courant that he is still awaiting toxicology reports that may further expose biological clues to Lanza’s violent act.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.